Nemours Children's Hospital, Delaware is seeking a full-time Medical Director of Apheresis with experience in cellular therapy collection and processing for a rapidly growing cell and gene therapy program. The successful candidate will play an integral role in the growth and expansion of the NCH-DE Apheresis Program in collaboration with the Division of Transplant and Cellular Therapy and Division of Pathology and Clinical Laboratory.
As Medical Director of Apheresis, the candidate will oversee all existing therapeutic and clinical apheresis services including plasmapheresis and erythrocytapheresis. Responsibilities also include the development of a comprehensive cellular collections service and participation in advancing Stem Cell Laboratory processes to meet the growing demand for cellular and gene therapies.
The NCH-DE offers patients advanced therapeutic products including CAR-T and gene therapies for sickle cell disease and thalassemia as well as clinical trials that extend novel therapies to patients including cord blood transplant for cerebral palsy and a SCIDS trial using TCR ab/CD19+ depleted grafts.
This position offers an excellent opportunity to contribute to a rapidly expanding and well-supported program, and substantial potential for professional growth. The Medical Director of Apheresis will work closely with the Lisa Dean Moseley Foundation Institute for Cancer and Blood Disorders team as we work to offer our patients state-of-the-art treatments.
Interested candidates should forward their formal CV to:
Marietta Lundberg, Administrative Director
Nemours Children's Health
Marietta.Lundberg@nemours.org
with a CC to :
Jessica Vega, Sr. Physician Recruiter
jessica.vega@nemours.org
Opportunities and Expectations for Leadership
- MD/DO degree
- Board Certified in Pediatrics/Hematology & Oncology, Clinical Pathology, or Anatomic and Clinical Pathology
- Additional Board Certification/eligibility/specialization in Transfusion Medicine preferred
- Demonstrated expertise in Apheresis
#J-18808-Ljbffr
